Cargando…
Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation
The search for disease-modifying agents targeted against Parkinson’s disease led us to rationally design a small array of six Anle138b-centered PROTACs, 7a,b, 8a,b and 9a,b, targeting αSynuclein (αSyn) aggregates for binding, polyubiquitination by the E3 ligase Cereblon (CRBN), and proteasomal degra...
Autores principales: | Pedrini, Martina, Iannielli, Angelo, Meneghelli, Lorenzo, Passarella, Daniele, Broccoli, Vania, Seneci, Pierfausto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221781/ https://www.ncbi.nlm.nih.gov/pubmed/37242709 http://dx.doi.org/10.3390/pharmaceutics15051467 |
Ejemplares similares
-
The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
por: Antonschmidt, Leif, et al.
Publicado: (2022) -
In Silico Study of the Interactions of Anle138b Isomer, an Inhibitor of Amyloid Aggregation, with Partner Proteins
por: Kondratyev, Maxim S., et al.
Publicado: (2022) -
Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b
por: Hosseini-Gerami, Layla, et al.
Publicado: (2023) -
Nanolipid-Trehalose Conjugates and Nano-Assemblies as Putative Autophagy Inducers
por: Colombo, Eleonora, et al.
Publicado: (2019) -
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
por: Wagner, Jens, et al.
Publicado: (2015)